Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003977 · ClinicalTrials.gov registry record · Phase 1
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer
A Phase 1 study, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00003977 is a Phase 1 study that has completed, run by Steward St. Elizabeth's Medical Center of Boston.
The verdict
NCT00003977, a Phase 1 study, has completed, sponsored by Steward St. Elizabeth's Medical Center of Boston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with recurrent or persistent cervical cancer that cannot be treated with surgery or radiation therapy.
Interventions
- PROCEDURE in vitro-treated peripheral blood stem cell transplantation
- BIOLOGICAL human papillomavirus 16 E7 peptide
Trial Details
| Field | Value |
|---|---|
| Start Date | 1999-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003977
The ClinicalTrials.gov registry entry for NCT00003977 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Steward St. Elizabeth's Medical Center of Boston, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which in vitro-treated peripheral blood stem cell transplantation is the first listed.
NCT00003977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003977 about?
NCT00003977 is a clinical study titled "Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer". RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients with recurrent or persistent cervical cancer that cannot be treated with surgery or radiation therapy.
What is the current status of trial NCT00003977?
This trial is currently completed. It is a Phase 1 study. The study started on 1999-11.
What interventions are being tested in trial NCT00003977?
The interventions under investigation include: in vitro-treated peripheral blood stem cell transplantation (PROCEDURE), human papillomavirus 16 E7 peptide (BIOLOGICAL).
Who is sponsoring clinical trial NCT00003977?
This trial is sponsored by Steward St. Elizabeth's Medical Center of Boston, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.